Attention-deficit/Hyperactivity Disorder.NCT02184598
Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With ADHD
A study testing Cognitive training in people with Attention-deficit/Hyperactivity Disorder., run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
Trial summary
Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo training. Read more about this study
- Who is it for?
- Ages 6 to 13 years
- Conditions the study is for
- Attention-deficit/Hyperactivity Disorder.
- What is being tested?
- Cognitive training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteBrazil
- Study dates
- Jul 2014to Dec 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 13 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Male or female, age 6 to 13 years, ADHD diagnosis (DSM-V)
- Medicated and stabilized individuals with psychostimulant with residual symptoms of inattention - mean scores of parents and teachers > or = 1)
Who cannot join
- Presence of other comorbid mental disorder that is clinically significant and requiring treatment at the time of entry in the protocol.
- intelligence quotient (IQ) < 80
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-003
About this study
Official title: Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo training. The cognitive training consists of 6 computerized games that are based on principles of neuroplastic change.
ADHD: current treatment - International clinical guidelines indicate that pharmacological interventions in particular stimulants are the first-line treatment for ADHD. However, about 30% of children affected by the disorder do not respond to medication alone, exhibit partial response or can not tolerate the adverse effects. In addition there is a group of parents who do not accept the use of medication for the treatment of ADHD in their children. In recent years cognitive training has received considerable attention as a treatment to ADHD. The evidence base for cognitive training programs are still forming with few randomized placebo-controlled studies. However, this approach seems to be effective either as a treatment for ADHD - and others cognitive disorders in childhood - or as a tool to enhance cognitive ability and school performance in children and adults. No previous study has evaluated this cognitive intervention in a clinical trial with placebo-controlled intervention and as an adjunctive treatment to medication. Additionally, the investigators will assess brain changes associated with this intervention using neuroimaging (fMRI).
Read the detailed description
Material and Methods Trial design Randomized clinical trial with placebo control. This study will compare the cognitive training program versus the placebo condition to assess the reduction on residual symptoms, the improvement in the neurocognitive function and brain activation changes in children and adolescents with ADHD receiving stimulants. Sixty subjects, six to thirteen years-old with ADHD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) will be randomly assigned to 12 weeks of cognitive or placebo training.
Participants To be included in the study children and adolescent need to meet the following criteria (a) age between 6-13 years, (b) a diagnosis of ADHD classified according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (5th edition), (c) medicated and stabilized with psychostimulants but partially restored - inattention SNAP score (mean scores of parents and teachers > or = 1), (d) a full scale intelligence quotient (IQ) of at least 80, (e) access to a computer with windows vista 7 and speakers, and access to internet. Participants will be excluded in case (a) another comorbid psychiatry diagnosis clinically significant and requiring treatment at the time of enter in the study protocol.
Sample Size Calculation There was no previous study that used the design proposed in this investigation. Considering a reduction 20% higher of the SNAP-IV scores in the active group intervention (stimulants + cognitive training), sample size in both groups of 27 participants and standard-deviation in the magnitude of half of the medium score in each group (moderate variability), the study will be able to detect a moderate effect size (ES = 0,4). Calculating a sample loss of 10% each group, we define a sample size per group of 30 individuals.
Cognitive intervention protocol:
A portuguese version of the new Cognitive Computerized Training was created with the partnership of Yale University research team.
The cognitive training program is composed by computerized exercises with six different games divided in multiples levels and sublevels with increasing difficulty. During the games, several neuropsychological domains are required from the participant such working memory, sustained attention, response inhibition and others. In each session the participant will play 6 games divided in 5 minutes blocks. The aim of these games is to engage and activate targeted neurocognitive systems This protocol will be run in schools. It will be consisted of 4 times/week sessions (3 times at school and 1 time at home) for 12 weeks with 30 min of duration.
The placebo cognitive training (control group) will contain the same exposure time of the active group but without any element regarding to the cognitive training.
Pharmacological protocol All subjects must be receiving pharmacological treatment for ADHD with a stable dose of stimulants for at least 1 month in doses not inferior of 0.3mg/kg/per day of methylphenidate or 30mg/per day of lisdexamphetamine. Any increase in doses during the protocol will be permitted.
Neuropsychological protocol An assessment before the beginning of the intervention and pos-treatment will be done by a trained neuropsychologist using three tests of a NIH toolbox (C8Kids platform): Flanker Test, Go/NoGo Test and List Sorting Test of Working Memory and a neuropsychological battery created by our team using six tests: CPT II (Conner´s Continuous Performance Test II), Digit Span, Spatial Span, Reaction Time Task, Trail Making Test and Picture Concepts.
Neuroimaging protocol A subgroup of 10 participants from each group will be drawn to a functional resonance exam (MRIf) before and immediately after the cognitive or placebo training. During the exam they will do a neuropsychological tests ( Go/NoGo; N-Back - working memory - and SAT - sustained attention test).
Statistical methods Statistical analyses will be performed with Statistical Package for the Social Sciences (SPSS) 12.0. The univariate analyses will be performed with the t student test / Mann-Whitney to continuous variables or Chi-Square test (X²) / Fischer test to categorical variables. The variables that present relationship with the outcomes will be maintained in multivariate models. The effective of the intervention over time will be assess through analyses of mixed models.
- Being tested
- Cognitive training, Placebo cognitive training
- Keywords
- ADHD, Cognitive training, fMRI, Cognitive function
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cognitive trainingBehavioural
12 weeks of cognitive training; 4 sessions/week; duration 30 min
Placebo cognitive trainingBehavioural
In the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory.
| Study group | Role | What they receive |
|---|---|---|
| Placebo cognitive training | Placebo comparator | In the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory. Receives: Behavioral: Placebo cognitive training |
| Cognitive training | Experimental | Cognitive training with 6 different games each of which gets progressively more difficult as children obtain proficiency. Receives: Behavioral: Cognitive training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in ADHD symptomatology
Measured by the SNAP scale filled by parents and teachers.
Measured: Baseline; 12 weeks.
Secondary outcomes (3)
Change in neuropsychological function.
Working memory, inhibitory control, executive function and delay aversion.
Measured: Baseline; 12 weeks.
Change in activation of front-striatal and parietal brain areas in functional magnetic resonance imaging (fMRI) during a neuropsychological test.
Measured: Baseline; 12 weeks.
Change in the hours and characteristic of internet use
measured by an appropriate scale (IAT - Internet Addiction Test)
Measured: Baseline; 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jul 2014 (estimated)
- Study startJul 2014
- Primary completionJul 2016 (estimated)
- Study completionDec 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention-deficit/Hyperactivity Disorder.Studies of the same condition, open and under way.
- More trials run by Hospital de Clinicas de Porto AlegreThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Sponsor type
- University, hospital or other
- Collaborators
- Yale University
- Responsible party
- Sponsor
- Investigators
- Marcelo Schmitz, MD PhD, Principal investigator, Hospital de Clinicas de Porto Alegre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02184598
- Sponsor's protocol ID
- 125002
- Status last verified
- Dec 2015
- First submitted
- 4 Apr 2014
- Last updated
- 22 Dec 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
- ClinicalTrials.gov ID
- NCT02184598
- Acronym / sponsor ID
- 125002
- Keywords
- ADHD, Cognitive training, fMRI, Cognitive function
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Hospital de Clinicas de Porto AlegreUniversity, hospital or other
- Collaborators
- Yale University
- Study start
- Jul 2014
- Primary completion
- Jul 2016 (estimated)
- Study completion
- Dec 2016 (estimated)
- First posted
- 9 Jul 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo training. The cognitive training consists of 6 computerized games that are based on principles of neuroplastic change.
ADHD: current treatment - International clinical guidelines indicate that pharmacological interventions in particular stimulants are the first-line treatment for ADHD. However, about 30% of children affected by the disorder do not respond to medication alone, exhibit partial response or can not tolerate the adverse effects. In addition there is a group of parents who do not accept the use of medication for the treatment of ADHD in their children. In recent years cognitive training has received considerable attention as a treatment to ADHD. The evidence base for cognitive training programs are still forming with few randomized placebo-controlled studies. However, this approach seems to be effective either as a treatment for ADHD - and others cognitive disorders in childhood - or as a tool to enhance cognitive ability and school performance in children and adults. No previous study has evaluated this cognitive intervention in a clinical trial with placebo-controlled intervention and as an adjunctive treatment to medication. Additionally, the investigators will assess brain changes associated with this intervention using neuroimaging (fMRI).
Detailed description
Material and Methods Trial design Randomized clinical trial with placebo control. This study will compare the cognitive training program versus the placebo condition to assess the reduction on residual symptoms, the improvement in the neurocognitive function and brain activation changes in children and adolescents with ADHD receiving stimulants. Sixty subjects, six to thirteen years-old with ADHD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) will be randomly assigned to 12 weeks of cognitive or placebo training.
Participants To be included in the study children and adolescent need to meet the following criteria (a) age between 6-13 years, (b) a diagnosis of ADHD classified according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (5th edition), (c) medicated and stabilized with psychostimulants but partially restored - inattention SNAP score (mean scores of parents and teachers > or = 1), (d) a full scale intelligence quotient (IQ) of at least 80, (e) access to a computer with windows vista 7 and speakers, and access to internet. Participants will be excluded in case (a) another comorbid psychiatry diagnosis clinically significant and requiring treatment at the time of enter in the study protocol.
Sample Size Calculation There was no previous study that used the design proposed in this investigation. Considering a reduction 20% higher of the SNAP-IV scores in the active group intervention (stimulants + cognitive training), sample size in both groups of 27 participants and standard-deviation in the magnitude of half of the medium score in each group (moderate variability), the study will be able to detect a moderate effect size (ES = 0,4). Calculating a sample loss of 10% each group, we define a sample size per group of 30 individuals.
Cognitive intervention protocol:
A portuguese version of the new Cognitive Computerized Training was created with the partnership of Yale University research team.
The cognitive training program is composed by computerized exercises with six different games divided in multiples levels and sublevels with increasing difficulty. During the games, several neuropsychological domains are required from the participant such working memory, sustained attention, response inhibition and others. In each session the participant will play 6 games divided in 5 minutes blocks. The aim of these games is to engage and activate targeted neurocognitive systems This protocol will be run in schools. It will be consisted of 4 times/week sessions (3 times at school and 1 time at home) for 12 weeks with 30 min of duration.
The placebo cognitive training (control group) will contain the same exposure time of the active group but without any element regarding to the cognitive training.
Pharmacological protocol All subjects must be receiving pharmacological treatment for ADHD with a stable dose of stimulants for at least 1 month in doses not inferior of 0.3mg/kg/per day of methylphenidate or 30mg/per day of lisdexamphetamine. Any increase in doses during the protocol will be permitted.
Neuropsychological protocol An assessment before the beginning of the intervention and pos-treatment will be done by a trained neuropsychologist using three tests of a NIH toolbox (C8Kids platform): Flanker Test, Go/NoGo Test and List Sorting Test of Working Memory and a neuropsychological battery created by our team using six tests: CPT II (Conner´s Continuous Performance Test II), Digit Span, Spatial Span, Reaction Time Task, Trail Making Test and Picture Concepts.
Neuroimaging protocol A subgroup of 10 participants from each group will be drawn to a functional resonance exam (MRIf) before and immediately after the cognitive or placebo training. During the exam they will do a neuropsychological tests ( Go/NoGo; N-Back - working memory - and SAT - sustained attention test).
Statistical methods Statistical analyses will be performed with Statistical Package for the Social Sciences (SPSS) 12.0. The univariate analyses will be performed with the t student test / Mann-Whitney to continuous variables or Chi-Square test (X²) / Fischer test to categorical variables. The variables that present relationship with the outcomes will be maintained in multivariate models. The effective of the intervention over time will be assess through analyses of mixed models.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Placebo cognitive training | Placebo comparator | Behavioral: Placebo cognitive trainingIn the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory. |
| Cognitive training | Experimental | Behavioral: Cognitive trainingCognitive training with 6 different games each of which gets progressively more difficult as children obtain proficiency. |
Who may qualify
- Ages
- 6 to 13 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Male or female, age 6 to 13 years, ADHD diagnosis (DSM-V)
- Medicated and stabilized individuals with psychostimulant with residual symptoms of inattention - mean scores of parents and teachers > or = 1)
Key exclusion criteria (2 listed)
- Presence of other comorbid mental disorder that is clinically significant and requiring treatment at the time of entry in the protocol.
- intelligence quotient (IQ) < 80
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cognitive training12 weeks of cognitive training; 4 sessions/week; duration 30 min | Behavioural | Cognitive training |
| Placebo cognitive trainingIn the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory. | Behavioural | Placebo cognitive training |
Primary outcome
Change in ADHD symptomatology
Time frame: Baseline; 12 weeks.
Measured by the SNAP scale filled by parents and teachers.
3 secondary outcomes
Change in neuropsychological function.
Time frame: Baseline; 12 weeks.
Change in activation of front-striatal and parietal brain areas in functional magnetic resonance imaging (fMRI) during a neuropsychological test.
Time frame: Baseline; 12 weeks.
Change in the hours and characteristic of internet use
Time frame: Baseline; 12 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2015.
Related trials for Attention-deficit/Hyperactivity Disorder.
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
Recruiting
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marcelo Schmitz, MD PhD principal investigator
Hospital de Clinicas de Porto Alegre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cognitive training in people with Attention-deficit/Hyperactivity Disorder., run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in ADHD symptomatology (time frame: Baseline; 12 weeks.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2015.